En tiempo real
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,74 EUR | 0,00 % |
|
-0,53 % | +4,47 % |
Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products, Consumer Health Products and Medical Devices
100,0
%
| 294 | 100,0 % | 328 | 100,0 % | +11,80 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Brazil
51,3
%
| 135 | 45,9 % | 168 | 51,3 % | +24,86 % |
Rest of Latin America
16,8
%
| 40 | 13,7 % | 55 | 16,8 % | +37,17 % |
Colombia
13,6
%
| 46 | 15,7 % | 45 | 13,6 % | -3,24 % |
Argentina
7,3
%
| 48 | 16,4 % | 24 | 7,3 % | -49,95 % |
Canada
6,0
%
| 11 | 3,9 % | 20 | 6,0 % | +73,39 % |
Other
5,0
%
| 13 | 4,4 % | 16 | 5,0 % | +26,27 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01/11/13 |
Jonathan Goodman
FOU | Founder | 56 | 01/11/13 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 20/06/16 |
Leopoldo Bosano
COO | Chief Operating Officer | - | - |
Monica Percario
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan Emblem
HRO | Human Resources Officer | - | 01/10/20 |
Amal Khouri
PRN | Corporate Officer/Principal | - | 01/08/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 06/01/14 |
Jonathan Goodman
FOU | Founder | 56 | 01/11/13 |
Robert Lande
BRD | Director/Board Member | 61 | 01/01/13 |
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01/11/13 |
Nicolás Spiguel
BRD | Director/Board Member | 48 | 01/01/20 |
Michael Tremblay
BRD | Director/Board Member | 71 | 01/01/19 |
Janice Murray
BRD | Director/Board Member | 58 | 01/01/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 101 283 482 | 55 223 453 ( 54,52 %) | 0 | 54,52 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
1 153 897 | 9.50% | 336 938 $ |
Información de la empresa
Knight Therapeutics, Inc.
3400 de Maisonneuve West Suite 1055
H3Z 3B8, Montréal
+514-484-4483
http://www.gud-knight.com![Dirección Knight Therapeutics Inc.(04K)](https://cdn.zonebourse.com/static/address/154565111.png)
Sector
Ventas por región
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,78 % | 72,21 mil M | |
+14,98 % | 9140,96 M | |
-23,31 % | 4332,29 M | |
+15,70 % | 4278,95 M | |
+32,83 % | 4152,49 M | |
+9,54 % | 2193,05 M | |
-33,37 % | 1978,39 M | |
+9,30 % | 1975,03 M | |
-46,20 % | 1678,88 M |
- Bolsa de valores
- Acciones
- Acción GUD
- Acción 04K
- Empresa Knight Therapeutics Inc.